Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Golam M Khandaker

Showing results (1-10 of 124) with videos related to

Pageof 13
Sort By:
International Journal of Epidemiology|September 30, 2019
Commentary: Causal associations between inflammation, cardiometabolic markers and schizophrenia: the known unknownsGolam M Khandaker
International Journal of Epidemiology|November 1, 2019
Commentary: Causal associations between inflammation, cardiometabolic markers and schizophrenia: the known unknownsGolam M Khandaker
Biological Psychiatry|June 22, 2019
Early-Life Biomarkers for Psychosis Risk in Young People: Another Nail in the Coffin for Cartesian DualismGolam M Khandaker
Current Topics in Behavioral Neurosciences|May 23, 2019
Cytokines, Oxidative Stress and Cellular Markers of Inflammation in SchizophreniaRachel Upthegrove, Golam M Khandaker
Psychopharmacology|June 4, 2015
Is there a role for immune-to-brain communication in schizophrenia?Golam M Khandaker, Robert Dantzer
JAMA|February 18, 2011
Cognitive and functional impairment after severe sepsisGolam M Khandaker, Peter B Jones
The Lancet. Psychiatry|March 2, 2023
Cytokines in psychosis: from mechanism towards treatment and predictionÉimear M Foley, Golam M Khandaker
Psychoneuroendocrinology|June 13, 2021
Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19Nils Kappelmann, Robert Dantzer, Golam M Khandaker
Harvard Review of Psychiatry|January 7, 2022
Prenatal and Childhood Immuno-Metabolic Risk Factors for Adult Depression and PsychosisNils Kappelmann, Benjamin I Perry, Golam M Khandaker
Brain, Behavior, & Immunity - Health|January 17, 2022
Neurocognitive Performance in Depressed Patients with low-grade inflammation and somatic symptomsMuzaffer Kaser, Éimear M Foley, Golam M Khandaker
Pageof 13

Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
International Journal of Epidemiology|September 30, 2019
Commentary: Causal associations between inflammation, cardiometabolic markers and schizophrenia: the known unknownsGolam M Khandaker
International Journal of Epidemiology|November 1, 2019
Commentary: Causal associations between inflammation, cardiometabolic markers and schizophrenia: the known unknownsGolam M Khandaker
Biological Psychiatry|June 22, 2019
Early-Life Biomarkers for Psychosis Risk in Young People: Another Nail in the Coffin for Cartesian DualismGolam M Khandaker
Current Topics in Behavioral Neurosciences|May 23, 2019
Cytokines, Oxidative Stress and Cellular Markers of Inflammation in SchizophreniaRachel Upthegrove, Golam M Khandaker
Psychopharmacology|June 4, 2015
Is there a role for immune-to-brain communication in schizophrenia?Golam M Khandaker, Robert Dantzer
JAMA|February 18, 2011
Cognitive and functional impairment after severe sepsisGolam M Khandaker, Peter B Jones
The Lancet. Psychiatry|March 2, 2023
Cytokines in psychosis: from mechanism towards treatment and predictionÉimear M Foley, Golam M Khandaker
Psychoneuroendocrinology|June 13, 2021
Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19Nils Kappelmann, Robert Dantzer, Golam M Khandaker
Harvard Review of Psychiatry|January 7, 2022
Prenatal and Childhood Immuno-Metabolic Risk Factors for Adult Depression and PsychosisNils Kappelmann, Benjamin I Perry, Golam M Khandaker
Brain, Behavior, & Immunity - Health|January 17, 2022
Neurocognitive Performance in Depressed Patients with low-grade inflammation and somatic symptomsMuzaffer Kaser, Éimear M Foley, Golam M Khandaker
Pageof 13